{"id":17142,"date":"2021-02-08T15:30:20","date_gmt":"2021-02-08T14:30:20","guid":{"rendered":"http:\/\/mabdesign.fr\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/"},"modified":"2024-12-16T16:17:00","modified_gmt":"2024-12-16T15:17:00","slug":"t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy","status":"publish","type":"post","link":"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/","title":{"rendered":"T2EVOLVE : a Breakthrough alliance boosting Europe to the Forefront of cancer immunotherapy"},"content":{"rendered":"

\"\"<\/p>\n

Feb 3rd 2021 – T2EVOLVE<\/strong> is a breakthrough alliance of academic and industry leaders in cancer immunotherapy which started in January 2021, under the European Union\u2019s Innovative Medicines Initiative (IMI). The key objective of T2EVOLVE is to accelerate development and to increase access of cancer patients to immunotherapy with reprogrammed immune cells. Reprogramming is accomplished by genetic engineering with a T cell receptor (TCR) or synthetic chimeric antigen receptor (CAR). To know more<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

T2EVOLVE: breakthrough alliance boosting Europe to the forefront of cancer immunotherapy.<\/p>\n","protected":false},"author":1,"featured_media":9367,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18],"tags":[],"class_list":["post-17142","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"\nT2EVOLVE : a Breakthrough alliance boosting Europe to the Forefront of cancer immunotherapy - MabDesign<\/title>\n<meta name=\"description\" content=\"T2EVOLVE: breakthrough alliance boosting Europe to the forefront of cancer immunotherapy.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"T2EVOLVE : a Breakthrough alliance boosting Europe to the Forefront of cancer immunotherapy - MabDesign\" \/>\n<meta property=\"og:description\" content=\"T2EVOLVE: breakthrough alliance boosting Europe to the forefront of cancer immunotherapy.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/\" \/>\n<meta property=\"og:site_name\" content=\"MabDesign\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-08T14:30:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-16T15:17:00+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/T2EVOLVE-Logo.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1716\" \/>\n\t<meta property=\"og:image:height\" content=\"319\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"alexis.mathias@kairios.fr\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:site\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"alexis.mathias@kairios.fr\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/\"},\"author\":{\"name\":\"alexis.mathias@kairios.fr\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\"},\"headline\":\"T2EVOLVE : a Breakthrough alliance boosting Europe to the Forefront of cancer immunotherapy\",\"datePublished\":\"2021-02-08T14:30:20+00:00\",\"dateModified\":\"2024-12-16T15:17:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/\"},\"wordCount\":87,\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/T2EVOLVE-Logo.png\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/\",\"url\":\"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/\",\"name\":\"T2EVOLVE : a Breakthrough alliance boosting Europe to the Forefront of cancer immunotherapy - MabDesign\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/T2EVOLVE-Logo.png\",\"datePublished\":\"2021-02-08T14:30:20+00:00\",\"dateModified\":\"2024-12-16T15:17:00+00:00\",\"description\":\"T2EVOLVE: breakthrough alliance boosting Europe to the forefront of cancer immunotherapy.\",\"breadcrumb\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/#primaryimage\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/T2EVOLVE-Logo.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/T2EVOLVE-Logo.png\",\"width\":1716,\"height\":319},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/mabdesign.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"T2EVOLVE : a Breakthrough alliance boosting Europe to the Forefront of cancer immunotherapy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"name\":\"Mabdesign\",\"description\":\"The Biotherapy Expert\",\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mabdesign.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\",\"name\":\"Mabdesign\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"width\":786,\"height\":233,\"caption\":\"Mabdesign\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/MabDesign_fr\",\"https:\/\/www.linkedin.com\/company\/mabdesign\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\",\"name\":\"alexis.mathias@kairios.fr\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"caption\":\"alexis.mathias@kairios.fr\"},\"sameAs\":[\"http:\/\/mabdesign.fr\"],\"url\":\"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"T2EVOLVE : a Breakthrough alliance boosting Europe to the Forefront of cancer immunotherapy - MabDesign","description":"T2EVOLVE: breakthrough alliance boosting Europe to the forefront of cancer immunotherapy.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/","og_locale":"en_US","og_type":"article","og_title":"T2EVOLVE : a Breakthrough alliance boosting Europe to the Forefront of cancer immunotherapy - MabDesign","og_description":"T2EVOLVE: breakthrough alliance boosting Europe to the forefront of cancer immunotherapy.","og_url":"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/","og_site_name":"MabDesign","article_published_time":"2021-02-08T14:30:20+00:00","article_modified_time":"2024-12-16T15:17:00+00:00","og_image":[{"width":1716,"height":319,"url":"http:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/T2EVOLVE-Logo.png","type":"image\/png"}],"author":"alexis.mathias@kairios.fr","twitter_card":"summary_large_image","twitter_creator":"@MabDesign_fr","twitter_site":"@MabDesign_fr","twitter_misc":{"Written by":"alexis.mathias@kairios.fr"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/#article","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/"},"author":{"name":"alexis.mathias@kairios.fr","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135"},"headline":"T2EVOLVE : a Breakthrough alliance boosting Europe to the Forefront of cancer immunotherapy","datePublished":"2021-02-08T14:30:20+00:00","dateModified":"2024-12-16T15:17:00+00:00","mainEntityOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/"},"wordCount":87,"publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/T2EVOLVE-Logo.png","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/","url":"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/","name":"T2EVOLVE : a Breakthrough alliance boosting Europe to the Forefront of cancer immunotherapy - MabDesign","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/#primaryimage"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/T2EVOLVE-Logo.png","datePublished":"2021-02-08T14:30:20+00:00","dateModified":"2024-12-16T15:17:00+00:00","description":"T2EVOLVE: breakthrough alliance boosting Europe to the forefront of cancer immunotherapy.","breadcrumb":{"@id":"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/#primaryimage","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/T2EVOLVE-Logo.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/T2EVOLVE-Logo.png","width":1716,"height":319},{"@type":"BreadcrumbList","@id":"https:\/\/mabdesign.fr\/en\/t2evolve-a-breakthrough-alliance-boosting-europe-to-the-forefront-of-cancer-immunotherapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mabdesign.fr\/en\/"},{"@type":"ListItem","position":2,"name":"T2EVOLVE : a Breakthrough alliance boosting Europe to the Forefront of cancer immunotherapy"}]},{"@type":"WebSite","@id":"https:\/\/mabdesign.fr\/en\/#website","url":"https:\/\/mabdesign.fr\/en\/","name":"Mabdesign","description":"The Biotherapy Expert","publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mabdesign.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mabdesign.fr\/en\/#organization","name":"Mabdesign","url":"https:\/\/mabdesign.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","width":786,"height":233,"caption":"Mabdesign"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/MabDesign_fr","https:\/\/www.linkedin.com\/company\/mabdesign\/"]},{"@type":"Person","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135","name":"alexis.mathias@kairios.fr","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","caption":"alexis.mathias@kairios.fr"},"sameAs":["http:\/\/mabdesign.fr"],"url":"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/17142","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/comments?post=17142"}],"version-history":[{"count":1,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/17142\/revisions"}],"predecessor-version":[{"id":26677,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/17142\/revisions\/26677"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media\/9367"}],"wp:attachment":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media?parent=17142"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/categories?post=17142"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/tags?post=17142"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}